SENISCA

About SENISCA

SENISCA is an award-winning biotech company from the University of Exeter, focused on modulating RNA biology to develop a new generation of senotherapeutic interventions for treating age-related diseases. The company targets cellular ageing (senescence) by developing RNA senotherapeutics that address the molecular mechanisms driving senescence, aiming to reverse its effects and improve health outcomes.

Products & Services

RNA Senotherapeutics:Therapeutic interventions targeting dysregulated RNA splicing to reverse cellular senescence and treat age-related diseases.

Oligonucleotide-based Therapies:Therapies designed to reset splicing factor levels and reprogram senescent cells for rejuvenation.

Dermatology-focused Programmes:Programmes targeting skin health using oligonucleotides and small molecules to address skin ageing.

Specialties

RNA Biology Senotherapeutics Cellular Senescence Reversal Age-related Disease Treatment Oligonucleotide Therapeutics Alternative Splicing Modulation Dermatology and Skin Health

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 4699000 MR: - FA: £3.7 million FAN: 4699000	D: 2024-03-18 FD: 2024-03-18	6 investors

Seed Latest

2024-03-18

$4.7M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Sarah Cole

Chief Executive Officer

L

Lorna Harries

Chief Scientific Officer

B

Ben Lee

Head of Discovery Research

T

Tim Schmidt

Chief Development Officer

A

Adam Clauss

Head of Dermatology and Early Preclinical Development

A

Alice Ghidini

Head of Oligonucleotide Development

View 28 more team members with Pro

Unlock Full Team Directory

Recent News

SENISCA Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised